{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T17:35:31Z","timestamp":1785432931592,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Health and Medical Research Council of Australia (NHMRC)","award":["1069417"],"award-info":[{"award-number":["1069417"]}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Imk Almene Fond, Denmark"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.phrs.2018.11.031","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T19:01:22Z","timestamp":1542913282000},"page":"215-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometry"],"prefix":"10.1016","volume":"139","author":[{"given":"Dinesh C.","family":"Indurthi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taima","family":"Qudah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian W.","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip K.","family":"Ahring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1864-6806","authenticated-orcid":false,"given":"Trevor M.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Balle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Chebib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan L.","family":"Absalom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 1","key":"10.1016\/j.phrs.2018.11.031_bib0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/brain\/118.1.61","article-title":"Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder","volume":"118","author":"Scheffer","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2018.11.031_bib0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jneumeth.2015.06.003","article-title":"Genetic models of focal epilepsies","volume":"260","author":"Boillot","year":"2016","journal-title":"J. Neurosci. Methods"},{"issue":"2","key":"10.1016\/j.phrs.2018.11.031_bib0015","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1124\/mol.106.023044","article-title":"Alpha 4 beta 2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine","volume":"70","author":"Moroni","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2018.11.031_bib0020","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00726-012-1456-y","article-title":"Potency of GABA at human recombinant GABA(A) receptors expressed in Xenopus oocytes: a mini review","volume":"44","author":"Karim","year":"2013","journal-title":"Amino Acids"},{"issue":"2","key":"10.1016\/j.phrs.2018.11.031_bib0025","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bph.12268","article-title":"The additional ACh binding site at the alpha4(+)\/alpha4(-) interface of the (alpha4beta2)2alpha4 nicotinic ACh receptor contributes to desensitization","volume":"170","author":"Benallegue","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2018.11.031_bib0030","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1124\/mol.106.030445","article-title":"Ca2+ permeability of the (alpha4)3(beta2)2 stoichiometry greatly exceeds that of (alpha4)2(beta2)3 human acetylcholine receptors","volume":"71","author":"Tapia","year":"2007","journal-title":"Mol. Pharmacol."},{"issue":"8","key":"10.1016\/j.phrs.2018.11.031_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161154","article-title":"Ligand binding at the 4-4 agonist-binding site of the 42 nAChR triggers receptor activation through a pre-activated conformational state","volume":"11","author":"Indurthi","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.phrs.2018.11.031_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158032","article-title":"Mutation linked to autosomal dominant nocturnal frontal lobe epilepsy reduces low-sensitivity alpha4beta2, and increases alpha5alpha4beta2, nicotinic receptor surface expression","volume":"11","author":"Nichols","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.phrs.2018.11.031_bib0045","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1124\/mol.108.054494","article-title":"Nicotine normalizes intracellular subunit stoichiometry of nicotinic receptors carrying mutations linked to autosomal dominant nocturnal frontal lobe epilepsy","volume":"75","author":"Son","year":"2009","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2018.11.031_bib0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ng1095-201","article-title":"A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy","volume":"11","author":"Steinlein","year":"1995","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.phrs.2018.11.031_bib0055","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/hmg\/6.6.943","article-title":"An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy","volume":"6","author":"Steinlein","year":"1997","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.phrs.2018.11.031_bib0060","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1124\/mol.107.044545","article-title":"Human nocturnal frontal lobe epilepsy: pharmocogenomic profiles of pathogenic nicotinic acetylcholine receptor beta-subunit mutations outside the ion channel pore","volume":"74","author":"Hoda","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2018.11.031_bib0065","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/316946","article-title":"CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy","volume":"68","author":"Phillips","year":"2001","journal-title":"Am. J. Hum. Genet."},{"issue":"2-3","key":"10.1016\/j.phrs.2018.11.031_bib0070","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.eplepsyres.2008.10.009","article-title":"A novel mutation of the nicotinic acetylcholine receptor gene CHRNA4 in sporadic nocturnal frontal lobe epilepsy","volume":"83","author":"Chen","year":"2009","journal-title":"Epilepsy Res."},{"issue":"1","key":"10.1016\/j.phrs.2018.11.031_bib0075","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1124\/jpet.107.120436","article-title":"An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo","volume":"323","author":"Timmermann","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2018.11.031_bib0080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bcp.2014.02.002","article-title":"Presence of multiple binding sites on alpha9alpha10 nAChR receptors alludes to stoichiometric-dependent action of the alpha-conotoxin, Vc1.1","volume":"89","author":"Indurthi","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2018.11.031_bib0085","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuropharm.2015.11.004","article-title":"Distinctive effects of nicotinic receptor intracellular-loop mutations associated with nocturnal frontal lobe epilepsy","volume":"102","author":"Weltzin","year":"2016","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.phrs.2018.11.031_bib0090","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1021\/jm050069n","article-title":"Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation","volume":"48","author":"Coe","year":"2005","journal-title":"J. Med. Chem."},{"issue":"30","key":"10.1016\/j.phrs.2018.11.031_bib0095","doi-asserted-by":"crossref","first-page":"10759","DOI":"10.1523\/JNEUROSCI.1509-11.2011","article-title":"Unraveling the high- and low-sensitivity agonist responses of nicotinic acetylcholine receptors","volume":"31","author":"Harpsoe","year":"2011","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2018.11.031_bib0100","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1124\/mol.106.023044","article-title":"alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine","volume":"70","author":"Moroni","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2018.11.031_bib0105","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1046\/j.1471-4159.1996.66020667.x","article-title":"Sustained nicotine exposure differentially affects alpha 3 beta 2 and alpha 4 beta 2 neuronal nicotinic receptors expressed in Xenopus oocytes","volume":"66","author":"Hsu","year":"1996","journal-title":"J. Neurochem."},{"issue":"15","key":"10.1016\/j.phrs.2018.11.031_bib0110","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1212\/WNL.0000000000001471","article-title":"Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function","volume":"84","author":"Conti","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2018.11.031_bib0115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fphys.2015.00022","article-title":"The role of nicotinic acetylcholine receptors in autosomal dominant nocturnal frontal lobe epilepsy","volume":"6","author":"Becchetti","year":"2015","journal-title":"Front. Physiol."},{"issue":"2","key":"10.1016\/j.phrs.2018.11.031_bib0120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrn1297","article-title":"Presynaptic ionotropic receptors and control of transmitter release","volume":"5","author":"Engelman","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2018.11.031_bib0125","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.neuron.2016.03.032","article-title":"Emerging molecular mechanisms of signal transduction in pentameric ligand-gated ion channels","volume":"90","author":"Nemecz","year":"2016","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.phrs.2018.11.031_bib0130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0987-7053(02)00294-0","article-title":"Mutations of the neuronal nicotinic acetylcholine receptors and their association with ADNFLE","volume":"32","author":"Itier","year":"2002","journal-title":"Neurophysiol. Clin."},{"issue":"7","key":"10.1016\/j.phrs.2018.11.031_bib0135","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1046\/j.1528-1157.2003.61102.x","article-title":"A new Chrna4 mutation with low penetrance in nocturnal frontal lobe epilepsy","volume":"44","author":"Leniger","year":"2003","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.phrs.2018.11.031_bib0140","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.seizure.2011.10.003","article-title":"Mutations in familial nocturnal frontal lobe epilepsy might be associated with distinct neurological phenotypes","volume":"21","author":"Steinlein","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.phrs.2018.11.031_bib0145","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1196\/annals.1417.026","article-title":"Modulation of cortical activation and behavioral arousal by cholinergic and orexinergic systems","volume":"1129","author":"Jones","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"25","key":"10.1016\/j.phrs.2018.11.031_bib0150","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1523\/JNEUROSCI.3882-03.2004","article-title":"Beta2-containing nicotinic receptors contribute to the organization of sleep and regulate putative micro-arousals in mice","volume":"24","author":"Lena","year":"2004","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2018.11.031_bib0155","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.conb.2012.03.005","article-title":"Thalamocortical interactions","volume":"22","author":"Sherman","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"issue":"2","key":"10.1016\/j.phrs.2018.11.031_bib0160","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1515\/revneuro-2014-0044","article-title":"Pathologic role of neuronal nicotinic acetylcholine receptors in epileptic disorders: implication for pharmacological interventions","volume":"26","author":"Ghasemi","year":"2015","journal-title":"Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.phrs.2018.11.031_bib0165","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/hmg\/ddp004","article-title":"Expression of mutant beta2 nicotinic receptors during development is crucial for epileptogenesis","volume":"18","author":"Manfredi","year":"2009","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.phrs.2018.11.031_bib0170","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.pbb.2012.10.014","article-title":"Mice expressing the ADNFLE valine 287 leucine mutation of the Beta2 nicotinic acetylcholine receptor subunit display increased sensitivity to acute nicotine administration and altered presynaptic nicotinic receptor function","volume":"103","author":"O\u2019Neill","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"18","key":"10.1016\/j.phrs.2018.11.031_bib0175","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1212\/WNL.0000000000001539","article-title":"Pearls & Oysters: a case of refractory nocturnal seizures: putting out fires without smoke","volume":"84","author":"Pavlakis","year":"2015","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.phrs.2018.11.031_bib0180","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2165\/11537850-000000000-00000","article-title":"A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation","volume":"49","author":"Faessel","year":"2010","journal-title":"Clin. Pharmacokinet."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818306789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818306789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T08:42:04Z","timestamp":1565253724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661818306789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":36,"alternative-id":["S1043661818306789"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2018.11.031","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometry","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2018.11.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}